Volume 12 Supplement 1
Abstracts from the 25th European Society for Animal Cell Technology Meeting: Cell Technologies for Innovative Therapies
The publication charges for this supplement were funded by the conference. The supplement editor is an employee of Merck Healthcare. However, the abstracts were selected by an independent scientific committee on behalf of ESACT. The editor therefore declares no competing interests.
Lausanne, Switzerland14-17 May 2017
Edited by Matthieu Stettler